Shay Capital’s Redhill Biopharma RDHL Stock Holding History

Shay Capital’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1	Closed	-$8K	–	545
2020 Q4	$8K	Buy	+1	New	+$8.99K	﹤0.01%	279

Other funds holding RDHL

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Creative Planning

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Shay Capital's RDHL Position: Q1 2021 in Review

Shay Capital sold out of Redhill Biopharma (RDHL) in Q1 2021, closing a stake of 1 share — an estimated $8K sold.

Shay Capital first reported a position in RDHL in Q4 2020 and held it in 1 quarter. The position peaked at $8K in Q4 2020. 55 funds tracked by Wall St. Rank hold RDHL as of Q1 2021.

Shay Capital reported no remaining Redhill Biopharma position as of Q1 2021 after selling out during the quarter.
Shay Capital sold 1 Redhill Biopharma share in Q1 2021, an estimated $8K.
Shay Capital first reported a position in Redhill Biopharma in Q4 2020 and held it in 1 quarter.
Shay Capital's Redhill Biopharma position peaked at $8K in Q4 2020.
55 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2021.

Based on Shay Capital's 13F filing for Q1 2021, filed 13 Aug 2021.